Updates are available Correction dated 2025-05-19
Click to view Correction: https://doi.org/10.1007/s00198-025-07522-0
-
Authors
Hin, H.
Tomson, J.
Newman, C.
Kurien, R.
Lay, M.
Cox, J.
Sayer, J.
Hill, M.
Emberson, J.
Armitage, J.
Clarke, R.
-
Funding
Funding for this research was provided by:
British Heart Foundation (PG/12/32/29544)
Medical Research Council
- License Information
-
More Information
Article History
Received: 2 June 2016
Accepted: 2 November 2016
First Online: 16 December 2016
Change Date: 19 May 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00198-025-07522-0
Compliance with ethical standards
: All participants provided written informed consent, and the study was approved by the National Research Ethics Service Committee (Oxford B), UK.
: None.
: Tishcon Corporation (Westbury, NY, USA) donated the active and placebo vitamin D capsules. The British Heart Foundation (PG/12/32/29544) and British Heart Foundation Centre for Research Excellence provided partial funding for the study. The Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) at the University of Oxford receives funding from the UK Medical Research Council, the British Heart Foundation and Cancer Research UK.
: Informed consent was obtained from all individual participants included in the study.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
